ClearPoint Neuro Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: ClearPoint Neuro Inc and Ginkgo Bioworks Holdings Inc are close in size by market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | DNA | |
|---|---|---|
Market Cap | $454.21M | $505.73M |
Sector | Health | Health |
52-Week High | $29.60 | $16.14 |
52-Week Low | $8.66 | $5.48 |
Enterprise Value | $488.79M | $607.68M |
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →